Quent Capital
DGX icon

Quent Capital’s Quest Diagnostics DGX Stock Holding History

Quent Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$42.4K Buy
166
+24
+17% +$5.55K ﹤0.01% 903
2026
Q2 		$30.1K Buy
142
+68
+92% +$13.3K ﹤0.01% 949
2026
Q1 		$14.5K Sell
74
-44
-37% -$8.55K ﹤0.01% 1079
2025
Q4 		$20.5K Hold
118
– – ﹤0.01% 985
2025
Q3 		$22.5K Buy
+118
New +$20.9K ﹤0.01% 825
2025
Q2 		– Sell
-3
Closed -$508 – 534
2025
Q1 		$508 Hold
3
– – ﹤0.01% 1253
2024
Q4 		$453 Buy
+3
New +$467 ﹤0.01% 1277
2023
Q1 		– Sell
-10
Closed -$1.58K – 1331
2022
Q4 		$1.58K Sell
10
-12
-55% -$1.72K ﹤0.01% 1178
2022
Q3 		$3K Buy
22
+12
+120% +$1.58K ﹤0.01% 1036
2022
Q2 		$1K Buy
+10
New +$1.36K ﹤0.01% 1094

Other funds holding DGX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Quent Capital's DGX Position: Q3 2026 in Review

Quent Capital increased its Quest Diagnostics (DGX) stake by 17% in Q3 2026, buying an estimated $5.55K and bringing the position to 166 shares worth $42.4K. The position accounts for ﹤0.01% of the portfolio, ranked #903.

Quent Capital first reported a position in DGX in Q2 2022 and has held it in 10 quarters since. 647 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Quent Capital held 166 shares of Quest Diagnostics worth $42.4K as of Q3 2026.
  • Quent Capital bought 24 Quest Diagnostics shares in Q3 2026, an estimated $5.55K.
  • Quest Diagnostics made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #903 holding.
  • Quent Capital first reported a position in Quest Diagnostics in Q2 2022 and has held it in 10 quarters since.
  • 647 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.